Inhibition of Inducible Nitric Oxide Synthase Expression by YS 49, a Synthetic Isoquinoline Alkaloid, in ROS 17/2.8 Cells Activated with and LPS |
Kang, Young-Jin
(Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University)
Kang, Sun-Young (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) Lee, Young-Soo (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) Park, Min-Kyu (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) Kim, Hye-Jung (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) Seo, Han-Geuk (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) Lee, Jae-Heun (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) YunChoi, Hye-Sook (Natural Products Research Institute, Seoul National University) Chang, Ki-Churl (Department of Pharmacology, College of Medicine, Institute of Health Sciences, Gyeongsang National University) |
1 | Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219-1222, 1992 DOI ScienceOn |
2 | Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 352: 351-364, 1995 PUBMED |
3 | Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheum 35: 207-212, 1996b DOI PUBMED |
4 | Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Evans TJ, Seddon S, Riveros-Moreno V, Macintyre I, Polak JM. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136: 5445-5453, 1995 DOI ScienceOn |
5 | Kang YJ, Seo SJ, Yun-Choi HS, Lee DH, Kim YM,Chang KC. A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7- dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock. J Pharmacol Exp Ther 301: 561-567, 2002 DOI ScienceOn |
6 | Mogi M, Kinpara K, Kondo A, Togari A. Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1. Biochem Pharmacol 58: 649-654, 1999 DOI ScienceOn |
7 | Mogi M, Kondo A, Kinpara K, Togari A. Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line. Life Sci 67: 1197- 1206, 2000 DOI ScienceOn |
8 | Parfitt AM. Bone-forming cells in clinical conditions. In Bone. Volume 1: the osteoblast and osteocyte. BK Hall, editor. Telford Press and CRC Press. Boca Raton, FL 351-429, 1990 |
9 | Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel- Pelletier J. Chondrocyte death in experimental osteoarthritis is nitric oxide synthase. J Rheumatol 11: 2509-2519, 2001 |
10 | Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37: 1062-1069, 1994 DOI ScienceOn |
11 | Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 110: 701-706, 1993 DOI PUBMED ScienceOn |
12 | Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 200: 142-148, 1994 DOI ScienceOn |
13 | Wang E A, Rosen V, D'Alessandro JS, Beuduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, Lapan P, Luxenberg DP, Mcquaid D, Moutsatsos KI, Nove J, Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224, 1990. DOI ScienceOn |
14 | Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T. Recon stituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res 16: 1453-1464, 2001 DOI ScienceOn |
15 | Tom VK, Schotland S, Green J. Inflammatory cytokines (IL-1alpha, TNF-alpha) and LPS modulate the Ca signaling pathway in osteoblasts. Am J Physiol 274: C1686-1698, 1998 DOI |
16 | Chae HJ, Kang JS, Byun JO, Han KS, Kim DU, Oh SM, Kim HM, Chae SW, Kim HR. Molecular mechanism of staurosporineinduced apoptosis in osteoblasts. Pharmacol Res 42: 373-381, 2000b DOI ScienceOn |
17 | Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257: 88-91, 1992 DOI PUBMED |
18 | Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH. Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate: creatinine ratio. Arthritis Rheum 39: 643-647, 1996a DOI ScienceOn |
19 | Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritis. J Clin Invest 96: 2357-2363, 1995 DOI ScienceOn |
20 | Fox SW, Chow JW. Nitric oxide synthase expression in bone cells. Bone 23: 1-6, 1998 DOI ScienceOn |
21 | Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282, 1998 DOI ScienceOn |
22 | Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13: 793-802, 1998 DOI ScienceOn |
23 | Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206: 15-21, 1995 DOI ScienceOn |
24 | Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336, 1994 DOI ScienceOn |
25 | Grabowski PS, Wright PK, van't Hof RJ, Helfrich MH, Oshima H, Ralston SH. Immunolocalisation of inducible nitric oxide synthase in the synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 36: 651-655, 1997 DOI PUBMED |
26 | Hilliquin P, Borderie D, Hernvann A, Menkes CJ, Ekindjian OG. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 40: 1512-1517, 1997. DOI ScienceOn |
27 | Ralston SH, Grabowski PS. Mechanisms of cytokine induced bone resorption: Role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 19: 29-33, 1996 DOI ScienceOn |
28 | Kang YJ, Koo EB, Lee YS, Yun-Choi HS, Chang KC.Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages. Br J Pharmacol 128: 357-364, 1999a DOI ScienceOn |
29 | Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147: 3915-3920, 1991 |
30 | Yun-Choi HS, Pyo M K, Park KM, Chang KC, Lee DH. Antithrombotic effects of YS-49 and YS-51S-1-naphthylmethyl analogs of higenamine. Thromb Res 301: 561-567, 2001 |
31 | Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 193: 398-405, 1993 DOI ScienceOn |
32 | Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96: 1631-1638, 1995 DOI ScienceOn |
33 | Ihbe A, Baumann G, Heinzmann U, Atkinson MJ. Loss of the differentiated phenotype precedes apoptosis of ROS 17/2.8 osteoblast-like cells. Calcif Tissue Int 63: 208-213, 1998 DOI ScienceOn |
34 | Niederberger E, Tegeder I, Schafer C, Seegel M, Grosch S, Geisslinger G. Opposite effects of rofecoxib on nuclear factor-kappa B and activating protein-1 activation. J Pharmacol Exp Ther 304: 1153-1160, 2003. DOI ScienceOn |
35 | Kang YJ, Lee YS, Lee GW, Lee DH, Ryu JC, Yun-Choi HS, Chang KC. Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root. J Pharmacol Exp Ther 291: 314-320, 1999b |
36 | Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38: 485- 491, 1995 DOI ScienceOn |
37 | Wetterwald A, Hoffstetter W, Cecchini MG, Lanske B, Wagner C, Fleisch H, Atkinson M. Characterization and cloning of the E11 antigen, a marker expression by rat osteoblasts and osteocytes. Bone 18: 125-132, 1996 DOI ScienceOn |
38 | Boileau C, Martel-Pelletier J, Moldovan F, Jouzeau JY, Netter P, Manning PT, Pelletier JP. The in situ up-regulation of chond- rocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arthritis Rheum 46: 2637-2647, 2002 DOI ScienceOn |
39 | Chae HJ, Chae SW, Kang JS, Bang BG, Cho SB, Park RK, So HS, Kim YK, Kim HM, Kim, HR. Dexamethasone suppresses tumor necrosis factor-alpha-induced apoptosis in osteoblasts: possible role for ceramide. Endocrinology 141: 2904-2913, 2000a DOI PUBMED ScienceOn |
40 | Armour KJ, Armour KE, van't Hof RJ, Reid DM, Wei XQ, Liew FY, Ralston SH. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44: 2790-2796, 2001 DOI ScienceOn |
41 | McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178: 749-754, 1993 DOI ScienceOn |
42 | Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681- 687, 1991 DOI ScienceOn |
43 | Manolagas SC, Jilka RL. Mechanisms of disease: bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332: 305-311, 1995 DOI PUBMED ScienceOn |
44 | Sioud M, Mellbye O, Forre O. Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 16: 125-134, 1998 PUBMED |
45 | Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY. Altered immune response in mice lacking inducible nitric oxide synthase. Nature 375: 408- 411, 1995 DOI ScienceOn |